YIH
ABMD

Y-Intercept (HK)’s Abiomed Inc ABMD Stock Holding History

Y-Intercept (HK)’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,141
Closed -$371K – 951
2021
Q3 		$371K Buy
+1,141
New +$387K 0.07% 415
2021
Q1 		– Sell
-4,175
Closed -$1.35M – 877
2020
Q4 		$1.35M Buy
+4,175
New +$1.15M 0.57% 19

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Y-Intercept (HK)'s ABMD Position: Q4 2021 in Review

Y-Intercept (HK) sold out of Abiomed Inc (ABMD) in Q4 2021, closing a stake of 1,141 shares — an estimated $371K sold.

Y-Intercept (HK) first reported a position in ABMD in Q4 2020 and held it in 2 quarters. The position peaked at $1.35M in Q4 2020. 496 funds tracked by Wall St. Rank hold ABMD as of Q4 2021.

  • Y-Intercept (HK) reported no remaining Abiomed Inc position as of Q4 2021 after selling out during the quarter.
  • Y-Intercept (HK) sold 1,141 Abiomed Inc shares in Q4 2021, an estimated $371K.
  • Y-Intercept (HK) first reported a position in Abiomed Inc in Q4 2020 and held it in 2 quarters.
  • Y-Intercept (HK)'s Abiomed Inc position peaked at $1.35M in Q4 2020.
  • 496 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2021.

Based on Y-Intercept (HK)'s 13F filing for Q4 2021, filed 14 Feb 2022.